How sweet it isn't: Diminished taste function affects cancer patients' food intake

by Alissa Nolden,University of Massachusetts AmherstAlissa Nolden is an assistant professor of food science at UMass Amherst. Credit: UMass AmherstThe simple pleasure of tasting and savoring foo

Updated on: May 09,2024 4

How sweet it isn't: Diminished taste function affects cancer patients' food intake

by Alissa Nolden,University of Massachusetts AmherstAlissa Nolden is an assistant professor of food science at UMass Amherst. Credit: UMass AmherstThe simple pleasure of tasting and savoring foo

Updated on:May 09,2024 4

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Updated on: December 30,2023 17

Patients with metastatic colorectal cancer may continue benefiting from immunotherapy after treatment discontinuation

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with

Updated on:December 30,2023 17

Blood cancer research points to new treatment for bone marrow cancer

byUniversity of VirginiaDeletion of IL-1R1 preferentially inhibits Jak2V617F mutant hematopoietic stem/progenitor cells.aA scheme on competitive BM transplantation approach to assess

Updated on: January 15,2024 19

Blood cancer research points to new treatment for bone marrow cancer

byUniversity of VirginiaDeletion of IL-1R1 preferentially inhibits Jak2V617F mutant hematopoietic stem/progenitor cells.aA scheme on competitive BM transplantation approach to assess

Updated on:January 15,2024 19

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint

Updated on: March 25,2024 18

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint

Updated on:March 25,2024 18

New, revised topics released in ACR appropriateness criteria

(HealthDay)—The latest edition of the American College of Radiology (ACR) Appropriateness Criteria has been released and includes 188 diagnostic imaging and interventional radiology topics, with 908 c

Updated on: May 05,2024 13

New, revised topics released in ACR appropriateness criteria

(HealthDay)—The latest edition of the American College of Radiology (ACR) Appropriateness Criteria has been released and includes 188 diagnostic imaging and interventional radiology topics, with 908 c

Updated on:May 05,2024 13

Physical exercise prevents nerve damage during chemotherapy, sports scientist shows

byUniversity of BaselSports therapy to combat side effects: Fiona Streckmann with a patient during a neurological examination. A tuning fork is used to test vibration sensation, which can be alt

Updated on: July 08,2024 0

Physical exercise prevents nerve damage during chemotherapy, sports scientist shows

byUniversity of BaselSports therapy to combat side effects: Fiona Streckmann with a patient during a neurological examination. A tuning fork is used to test vibration sensation, which can be alt

Updated on:July 08,2024 0

Metabolite from pomegranates improves the function of immune cells in their fight against cancer

byEcole Polytechnique Federale de LausanneGraphical abstract. Credit:Immunity(2022). DOI: 10.1016/j.immuni.2022.09.014Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Ger

Updated on: January 04,2024 6

Metabolite from pomegranates improves the function of immune cells in their fight against cancer

byEcole Polytechnique Federale de LausanneGraphical abstract. Credit:Immunity(2022). DOI: 10.1016/j.immuni.2022.09.014Researchers from the Georg-Speyer-Haus in Frankfurt am Main, Ger

Updated on:January 04,2024 6

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for

Updated on: January 04,2024 12

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for

Updated on:January 04,2024 12

New drug combinations could improve therapies for breast cancer, other aggressive cancers

by Angela Yeager,Oregon Health & Science UniversityQuantification of CD8+T cells by multispectral flow cytometry in an ex vivo co-culture assay. Credit:Cell Reports Medicine&nbsp

Updated on: September 10,2024 0

New drug combinations could improve therapies for breast cancer, other aggressive cancers

by Angela Yeager,Oregon Health & Science UniversityQuantification of CD8+T cells by multispectral flow cytometry in an ex vivo co-culture assay. Credit:Cell Reports Medicine&nbsp

Updated on:September 10,2024 0

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on: May 07,2024 12

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on:May 07,2024 12

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on: January 10,2024 8

How do we know health screening programs work?

by Christian Yates,The ConversationLead-time bias can appear to make a treatment more effective than it actually is, if the perceived post-diagnosis survival time increases while the course of d

Updated on:January 10,2024 8

Researcher puts focus on the health of Latina breast cancer survivors

by Katharine Gammon,University of Southern CaliforniaCredit: AI-generated imageBreast cancer is the leading cause of cancer death among Latinas in the United States. Latinas are also twice as li

Updated on: June 11,2024 7

Researcher puts focus on the health of Latina breast cancer survivors

by Katharine Gammon,University of Southern CaliforniaCredit: AI-generated imageBreast cancer is the leading cause of cancer death among Latinas in the United States. Latinas are also twice as li

Updated on:June 11,2024 7